0001209191-19-037479.txt : 20190617 0001209191-19-037479.hdr.sgml : 20190617 20190617182629 ACCESSION NUMBER: 0001209191-19-037479 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190613 FILED AS OF DATE: 20190617 DATE AS OF CHANGE: 20190617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shak Steven CENTRAL INDEX KEY: 0001337334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 19902304 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-13 0 0001131324 GENOMIC HEALTH INC GHDX 0001337334 Shak Steven 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Scientific Officer Common Stock 2019-06-13 4 M 0 25000 31.12 A 258795 I Held by the Shak Family Trust Common Stock 2019-06-13 4 S 0 24191 51.9266 D 234604 I Held by the Shak Family Trust Common Stock 2019-06-13 4 S 0 809 52.4301 D 233795 I Held by the Shak Family Trust Common Stock 2019-06-14 4 M 0 10550 31.12 A 244345 I Held by the Shak Family Trust Common Stock 2019-06-14 4 S 0 8886 51.5441 D 235459 I Held by the Shak Family Trust Common Stock 2019-06-14 4 S 0 1664 52.2731 D 233795 I Held by the Shak Family Trust Employee Stock Option (right to buy) Holding 31.12 2019-06-13 4 M 0 25000 0.00 D 2025-02-13 Common Stock 25000 10550 D Employee Stock Option (right to buy) Holding 31.12 2019-06-14 4 M 0 10550 0.00 D 2025-02-13 Common Stock 10550 0 D Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 5, 2019. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $51.29 to $52.28. Represents weighted average sale price. Actual sale prices ranged from $52.29 to $52.50. Represents weighted average sale price. Actual sale prices ranged from $51.14 to $52.11. Represents weighted average sale price. Actual sale prices ranged from $52.16 to $52.39. The option became exercisable as to 25% of the shares on February 13, 2016, and becomes exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2019-06-17